Journal of Korean Medical Science10.3346/jkms.1994.9.2.155199492155The tumor necrosis factor beta * 1 allele is linked significantly to HLA-DR8 in Koreans with atrophic autoimmune thyroiditis who are positive for thyrotropin receptor blocking antibodyJae Hoon Chung, Bo Youn Cho, Hong Kyu Lee, Tai Gyu Kim, Hoon Han, Chang Soon Koh,,
Clinical Endocrinology10.1111/j.1365-2265.1995.tb02619.x1995434465-471High prevalence and little change in TSH receptor blocking antibody titres with thyroxine and antithyroid drug therapy in patients with non-goitrous autoimmune thyroiditisBo Youn Cho, Won Bae Kim, Jae Hoon Chung, Ka-Hee Yi, Young Kee Shong, Hong Kyu Lee, Chang-Soon Koh,
Thyroid10.1089/thy.2005.15.104720051591047-1054Sensitive Thyrotropin and Thyrotropin-Receptor Antibody Determinations One Month After Discontinuation of Antithyroid Drug Treatment as Predictors of Relapse in Graves' DiseaseBeate Quadbeck, Rudolf Hoermann, Ulla Roggenbuck, Susanne Hahn, Klaus Mann, Onno E. Janssen
Yearbook of Endocrinology10.1016/s0084-3741(09)79286-82009200989-91Long-Term Follow-Up of Antithyroid Peroxidase Antibodies in Patients with Chronic Autoimmune Thyroiditis (Hashimoto's Thyroiditis) Treated with LevothyroxineM. Schott,
Journal of Korean Medical Science10.3346/jkms.1993.8.5.355199385355Negative correlation between the conversion of thyrotropin receptor-bound blocking type thyrotropin receptor antibody to the stimulating type by anti-human IgG antibodies and the biological activity of blocking type thyrotropin receptor antibodyBo Youn Cho, Min Ho Shong, Jae Hoon Chung, Hong Kyu Lee, Chang Soon Koh, Hun Ki Min,,
Biochemical and Biophysical Research Communications10.1016/s0006-291x(05)81182-9199118021118-1124Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patientsShinji Kosugi, Toshiaki Ban, Takashi Akamizu, Leonard D. Kohn,
Yearbook of Endocrinology10.1016/s0084-3741(08)70103-320072007188-191Serum Thyrotropin Receptor Antibodies Concentrations in Patients with Graves' Disease Before, at the End of Methimazole Treatment, and After Drug Withdrawal: Evidence That the Activity of Thyrotropin Receptor Antibody and/or Thyroid Response Modify During the Observation PeriodE.L. Mazzaferri,
Thyroid10.1089/thy.1999.9.393199994393-399Two Graves' Disease Patients Who Spontaneously Developed Hypothyroidism After Antithyroid Drug Treatment: Characteristics of Epitopes for Thyrotropin Receptor AntibodiesHYUN-KYUNG CHUNG, WON BAE KIM, DO JOON PARK, LEONARD D. KOHN, KAZUO TAHARA, BO YOUN CHO
Yearbook of Endocrinology10.1016/s0084-3741(10)79469-520102010128-129Prevalence and Functional Significance of Thyrotropin Receptor Blocking Antibodies in Children and Adolescents with Chronic Lymphocytic ThyroiditisM. Schott,
Journal of Endocrinological Investigation10.1007/bf03345253200326111076-1080Recombinant monoclonal thyrotropin-stimulation blocking antibody (TSBAb) established from peripheral lymphocytes of a hypothyroid patient with primary myxedemaK. Moriyama, J. Okuda, M. Saijo, Y. Hattori, N. Kanamoto, Y. Hataya, F. Matsuda, T. Mori, K. Nakao, Takashi Akamizu,,